A study on the clinical efficacy of tigecycline in patients with severe infections showed that when the albumin(ALB) level < 26 g/L and the fAUC0–24 h/MIC > 0.9, the clinical antibacterial efficacy was reduced by nearly half of that in patients with an albumin level > 26 g/L [19]. Here, ALB is linked to infection.